The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls-Reference-Cited by-同舟云学术

The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls

Published:2011-01-12 Issue:5 Volume:152 Page:561-569
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Hill Brian T.,Rybicki Lisa,Bolwell Brian J.,Smith Stephen,Dean Robert,Kalaycio Matt,Pohlman Brad,Tench Shawnda,Sobecks Ronald,Andresen Steven,Copelan Edward,Sweetenham John

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08549.x/fullpdf

Reference27 articles.

1. Late congestive heart failure after hematopoietic cell transplantation;Armenian;Journal of Clinical Oncology,2008

2. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity;van Besien;Bone Marrow Transplantation,1995

3. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study;Bhatia;Blood,2005

4. Autologous hematopoietic cell transplantation non-Hodgkin’s lymphoma: 100 month follow-up;Bolwell;Bone Marrow Transplantation,2002

5. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin’s lymphoma;Brown;Journal of Clinical Oncology,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium;Journal of Clinical Oncology;2024-08-02

2. A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy;Nature Medicine;2024-07-08

3. What clinicians should know about surrogate end points in hematologic malignancies;Blood;2024-07-04

4. Allogeneic Hematopoietic Stem Cell Transplant;Comprehensive Hematology and Stem Cell Research;2024

5. Development and validation of CT‑based radiomics model of PET-negative residual CT masses: a potential biomarker for predicting relapse‑free survival in non-Hodgkin lymphoma patients showing complete metabolic response;Abdominal Radiology;2023-10-27